TNFAIP8 and liver cancer: In addition, the data from Human Protein Atlas demonstrated that a higher expression of TNFAIP8 in liver tumors significantly reduced (21%) the 5-year survival rate of liver cancer patients compared with TNFAIP8-lower-expressing liver tumors suggesting that high expression of TNFAIP8 in liver tumors is associated with poor prognosis in liver cancer patients (Fig. 1e) (https://www.proteinatlas.org/search/TNFAIP8; accessed November 12, 2018).